Clinical Pharmacology & TherapeuticsVolume 81, Issue 5 p. 634-635 Letter to the Editor Glutathione-S-Transferase (GST) M1 Null Genotype and Combined GSTM1 and GSTT1 Null Genotypes as a Risk Factor for Alcoholic Mild Liver Dysfunction K Oniki, K Oniki Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorK Ueda, K Ueda Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorM Hori, M Hori Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorS Mihara, S Mihara Japanese Red Cross Kumamoto Health Care Center, Kumamoto, JapanSearch for more papers by this authorT Marubayashi, T Marubayashi Japanese Red Cross Kumamoto Health Care Center, Kumamoto, JapanSearch for more papers by this authorK Nakagawa, Corresponding Author K Nakagawa kazukon@gpo.kumamoto-u.ac.jp Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this author K Oniki, K Oniki Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorK Ueda, K Ueda Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorM Hori, M Hori Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this authorS Mihara, S Mihara Japanese Red Cross Kumamoto Health Care Center, Kumamoto, JapanSearch for more papers by this authorT Marubayashi, T Marubayashi Japanese Red Cross Kumamoto Health Care Center, Kumamoto, JapanSearch for more papers by this authorK Nakagawa, Corresponding Author K Nakagawa kazukon@gpo.kumamoto-u.ac.jp Division of Pharmacology and Therapeutics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, JapanSearch for more papers by this author First published: 28 February 2007 https://doi.org/10.1038/sj.clpt.6100123Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume81, Issue5Obesity PandemicMay 2007Pages 634-635 RelatedInformation